Xiaojing Lan

494 total citations
10 papers, 238 citations indexed

About

Xiaojing Lan is a scholar working on Molecular Biology, Oncology and Biochemistry. According to data from OpenAlex, Xiaojing Lan has authored 10 papers receiving a total of 238 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Biochemistry. Recurrent topics in Xiaojing Lan's work include Epigenetics and DNA Methylation (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Amino Acid Enzymes and Metabolism (2 papers). Xiaojing Lan is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Amino Acid Enzymes and Metabolism (2 papers). Xiaojing Lan collaborates with scholars based in China and Norway. Xiaojing Lan's co-authors include Min Huang, Meiyu Geng, Shuai Tang, Jian Ding, Yi Chen, Jun Xu, Chenchu Lin, Xiaotong Yang, Hanlin Zeng and Nan Jin and has published in prestigious journals such as Cancer Cell, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Xiaojing Lan

10 papers receiving 236 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaojing Lan China 8 168 84 40 32 30 10 238
Hon Yan Kelvin Yip Australia 7 177 1.1× 106 1.3× 56 1.4× 58 1.8× 28 0.9× 9 321
Paul Gonzales United States 7 219 1.3× 100 1.2× 47 1.2× 36 1.1× 17 0.6× 19 360
Yinglei Gao China 12 194 1.2× 101 1.2× 38 0.9× 57 1.8× 52 1.7× 21 296
Marty J. Heslin United States 5 245 1.5× 104 1.2× 51 1.3× 33 1.0× 20 0.7× 7 329
Jan Roger Olsen Norway 7 192 1.1× 96 1.1× 74 1.9× 19 0.6× 55 1.8× 9 293
Charina Ortega United States 3 220 1.3× 71 0.8× 31 0.8× 19 0.6× 19 0.6× 4 294
Heng Lungh Choo Malaysia 5 191 1.1× 117 1.4× 72 1.8× 24 0.8× 28 0.9× 7 304
Shengyong Yang China 13 187 1.1× 103 1.2× 29 0.7× 73 2.3× 48 1.6× 18 356
Mohammed U. Syed United States 2 233 1.4× 126 1.5× 50 1.3× 18 0.6× 73 2.4× 5 311
Kaoru Mitsuhashi Japan 4 314 1.9× 93 1.1× 36 0.9× 49 1.5× 27 0.9× 7 389

Countries citing papers authored by Xiaojing Lan

Since Specialization
Citations

This map shows the geographic impact of Xiaojing Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojing Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojing Lan more than expected).

Fields of papers citing papers by Xiaojing Lan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojing Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojing Lan. The network helps show where Xiaojing Lan may publish in the future.

Co-authorship network of co-authors of Xiaojing Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojing Lan. A scholar is included among the top collaborators of Xiaojing Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojing Lan. Xiaojing Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Lan, Xiaojing, et al.. (2025). Discovery of 2(1H)-Quinoxalinone Derivatives as Potent and Selective MAT2A Inhibitors for the Treatment of MTAP-Deficient Cancers. Journal of Medicinal Chemistry. 68(2). 1222–1244. 4 indexed citations
2.
Liu, Yingluo, Xiaojing Lan, Tao Yuan, et al.. (2024). Oncogenic KRAS Induces Arginine Auxotrophy and Confers a Therapeutic Vulnerability to SLC7A1 Inhibition in Non–Small Cell Lung Cancer. Cancer Research. 84(12). 1963–1977. 20 indexed citations
3.
Tang, Shuai, Tao Yuan, Yuting Hu, et al.. (2023). Tetrandrine synergizes with MAPK inhibitors in treating KRAS-mutant pancreatic ductal adenocarcinoma via collaboratively modulating the TRAIL-death receptor axis. Pharmacological Research. 197. 106955–106955. 5 indexed citations
4.
Gao, Dingding, Shuai Tang, Yixin Cen, et al.. (2023). Discovery of Novel Drug-like PHGDH Inhibitors to Disrupt Serine Biosynthesis for Cancer Therapy. Journal of Medicinal Chemistry. 66(1). 285–305. 11 indexed citations
5.
Liang, Yuan, Xin‐Wei Shi, Xiaojing Lan, et al.. (2022). Discovery of PHGDH inhibitors by virtual screening and preliminary structure–activity relationship study. Bioorganic Chemistry. 121. 105705–105705. 11 indexed citations
6.
Deng, Wenjia, Shuai Tang, Xiaojing Lan, et al.. (2018). Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy. European Journal of Medicinal Chemistry. 148. 140–153. 14 indexed citations
7.
Zheng, Qiangang, Shuai Tang, Xian-Lei Fu, et al.. (2017). Discovery and structure-activity-relationship study of novel conformationally restricted indane analogues for mutant isocitric dehydrogenase 1 (IDH1) inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(23). 5262–5266. 15 indexed citations
8.
Tang, Shuai, Yi‐Chang Su, Xiaojing Lan, et al.. (2017). Discovery of a class of diheteroaromatic amines as orally bioavailable CDK1/4/6 inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(23). 5332–5336. 9 indexed citations
9.
Zeng, Hanlin, Jia Qu, Nan Jin, et al.. (2016). Feedback Activation of Leukemia Inhibitory Factor Receptor Limits Response to Histone Deacetylase Inhibitors in Breast Cancer. Cancer Cell. 30(3). 459–473. 134 indexed citations
10.
Wang, Wen-Qiong, et al.. (2014). Merremins A–G, Resin Glycosides from Merremia hederacea with Multidrug Resistance Reversal Activity. Journal of Natural Products. 77(10). 2234–2240. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hon Yan Kelvin Yip Breakdown of academic impact, for papers by Paul Gonzales Breakdown of academic impact, for papers by Yinglei Gao Breakdown of academic impact, for papers by Marty J. Heslin Breakdown of academic impact, for papers by Jan Roger Olsen Breakdown of academic impact, for papers by Charina Ortega Breakdown of academic impact, for papers by Heng Lungh Choo Breakdown of academic impact, for papers by Shengyong Yang Breakdown of academic impact, for papers by Mohammed U. Syed Breakdown of academic impact, for papers by Kaoru Mitsuhashi
Rankless by CCL
2026